The Stretta procedure is an endoluminal radiofrequency energy delivery system for the treatment of gastroesophageal reflux disease (GERD).
Dr Peter Meier and colleagues from Germany presented, for the first time, the Stretta treatment experience from European centers.
The team assessed 60 patients with a history of GERD from 6 European centers who underwent Stretta treatment from 2001 to 2003.
The team found that all patients were at least partly responsive to daily proton-pump inhibitors.
|Mean total reflux time improved from 17% to 9%|
|Scandinavian Journal of Gastroenterology|
Esophageal motility, endoscopy, and ambulatory 24-hour pH studies were done in all patients at baseline and 6 and 12 months after treatment.
The team evaluated medication use, satisfaction, GERD-health-related quality of life, 24-hour pH-metry, manometry, and endoscopy.
At 12 months after treatment, 75% of the patients needed no medication or less medication than before treatment.
These patients were more satisfied with their symptom control, and had statistically significantly fewer GERD symptoms.
The team noted that the mean lower esophageal sphincter pressure improved from 15 to 17 mmHg, and mean total reflux time from 17% to 9%.
In addition, the researchers observed that quality of life, and overall physical and mental health improved significantly.
Dr Meier's team concluded, "The experience with the Stretta procedure performed at centers in Europe confirms that it is well tolerated and effective in the treatment of GERD."
"It has a favorable impact on medication requirements, lower esophageal sphincter pressure, esophageal acid exposure, and GERD symptom scores."
"The Stretta procedure should be considered for patients who are not satisfied with drug therapy, and who are considering anti-reflux surgery."